Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert W Haasnoot

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Journal of Reproductive Immunology|July 8, 2010
The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birthHenriette Svarre Nielsen, Marian D Witvliet, Rudi Steffensen, et al.
HLA|April 1, 2020
HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid levelCynthia S M Kramer, Johan Koster, Geert W Haasnoot, et al.
Transplantation|August 16, 2022
Impact of Sensitization on Waiting Time Prior to Kidney Transplantation in GermanyDaniel Zecher, Florian Zeman, Thomas Drasch, et al.
Frontiers in Immunology|November 12, 2014
Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface ExpressionMoshe Israeli, Dave L Roelen, Mary Carrington, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 6, 2017
Paternal HLA-C is a risk factor in unexplained recurrent miscarriageTess Meuleman, Geert W Haasnoot, Jan M M van Lith, et al.
Frontiers in Genetics|October 8, 2024
Proficiency testing within EurotransplantYvonne M Zoet, Sebastiaan Heidt, Marissa J H van der Linden-van Oevelen, et al.
Investigative Ophthalmology & Visual Science|December 31, 2005
HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosisWillem Maat, Geert W Haasnoot, Frans H J Claas, et al.
Transplantation|June 9, 2023
Immunized Patients Face Reduced Access to Transplantation in the Eurotransplant Kidney Allocation SystemHans de Ferrante, Bart Smeulders, Ineke Tieken, et al.
Immunogenetics|October 4, 2014
HLA dosage effect in narcolepsy with cataplexyAstrid van der Heide, Willem Verduijn, Geert W Haasnoot, et al.
Transplant Immunology|December 4, 2020
A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donorLisa Mumford, Susan V Fuggle, Jaume Martorell, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Journal of Reproductive Immunology|July 8, 2010
The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birthHenriette Svarre Nielsen, Marian D Witvliet, Rudi Steffensen, et al.
HLA|April 1, 2020
HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid levelCynthia S M Kramer, Johan Koster, Geert W Haasnoot, et al.
Transplantation|August 16, 2022
Impact of Sensitization on Waiting Time Prior to Kidney Transplantation in GermanyDaniel Zecher, Florian Zeman, Thomas Drasch, et al.
Frontiers in Immunology|November 12, 2014
Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface ExpressionMoshe Israeli, Dave L Roelen, Mary Carrington, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 6, 2017
Paternal HLA-C is a risk factor in unexplained recurrent miscarriageTess Meuleman, Geert W Haasnoot, Jan M M van Lith, et al.
Frontiers in Genetics|October 8, 2024
Proficiency testing within EurotransplantYvonne M Zoet, Sebastiaan Heidt, Marissa J H van der Linden-van Oevelen, et al.
Investigative Ophthalmology & Visual Science|December 31, 2005
HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosisWillem Maat, Geert W Haasnoot, Frans H J Claas, et al.
Transplantation|June 9, 2023
Immunized Patients Face Reduced Access to Transplantation in the Eurotransplant Kidney Allocation SystemHans de Ferrante, Bart Smeulders, Ineke Tieken, et al.
Immunogenetics|October 4, 2014
HLA dosage effect in narcolepsy with cataplexyAstrid van der Heide, Willem Verduijn, Geert W Haasnoot, et al.
Transplant Immunology|December 4, 2020
A Europe wide acceptable mismatch program will enable transplantation of long waiting highly sensitised patients with a compatible donorLisa Mumford, Susan V Fuggle, Jaume Martorell, et al.
Pageof 8